Human chorionic gonadotrophin (hCG) is a hormone produced during pregnancy and present at the implantation site and in the maternal blood. Pregnancy has been proposed to represent a controlled state of inflammation at an early stage at the implantation site and later, systemically extended to the maternal circulation. Earlier, we reported that hCG can inhibit the development of diabetes in NOD mice and LPS-induced septic shock in a murine model. We hypothesize that hCG can contribute to the reduction of inflammation by modifying M function. Here, the TG-induced peritonitis model for inflammation was used to investigate the effect of hCG on cytokine production and cell recruitment in vivo. hCG pretreatment in TG-induced peritonitis increased the number of peritoneal cells, especially PMN and monocytes, compared with mice injected with TG only. This increased cell number was partially explained by increased cell survival induced by hCG. Despite the cellular infiltrate, hCG pretreatment decreased i.p. TNF-␣, IL-6, PTX3, CCL3, and CCL5 levels. By depleting peritoneal resident M using clodronate liposomes prior to the application of hCG and the TG trigger, we established that M are the main responsive cells to hCG, as the suppressed TNF-␣ and IL-6 production and increased PMN influx are abolished in their absence. Together, these data suggest that hCG contributes to the controlled inflammatory state of pregnancy by regulating M proinflammatory function.
Introduction
Studies about the role of the maternal immune system during pregnancy have focused mainly on the immune response toward the fetus [1] . There are two distinct immunological interfaces in pregnancy: locally in the decidua between maternal immune cells and fetal trophoblasts and systemically between circulating maternal immune cells and the syncytiotrophoblasts that form the placental villous surface. This syncytiotrophoblast layer releases hCG and cellular microparticles into the maternal blood and interacts with maternal immune cells. Recently, pregnancy is proposed to be a controlled state of inflammation [2] . At an early stage, the inflammation is predominantly present at the implantation site, and later, in the first trimester of pregnancy, this is extended to the maternal circulation. This systemic inflammatory response in normal pregnancy is characterized by leukocytosis [3] , increased monocyte priming [4] , increased phagocytic activity [5] , and the production of proinflammatory cytokines including IL-6, IL-12, and TNF-␣ [6, 7] . It has been suggested that these inflammatory changes can be as strong as those observed in patients with sepsis but surprisingly, do not seem to harm the mother and fetus in any way [8] . This indicates that pregnancy-specific factors help to control this inflammatory response.
hCG is a pregnancy hormone mainly secreted by trophoblasts. It can be detected in urine and blood, indicating that hCG is present at both immunological interfaces between mother and fetus. hCG levels reach the highest in the first trimester of pregnancy, then decline sharply to low levels until the end. The most well-known function of hCG is its role in endocrine regulation, but data are accumulating about its potential immunoregulating properties. Earlier, we showed that hCG can inhibit the development of diabetes in NOD mice [9] and LPS-induced SIRS [10] . It has been shown recently that hCG prevents the development of Sjögren's syndrome-like salivary gland exocrinopathy in mice [11] .
During normal pregnancy, high numbers of M occur in the decidua, and increased numbers of monocytes are found in the maternal circulation [12] [13] [14] . M play an essential role in the maternal defense against microorganisms and in the removal of apoptotic cells from the placenta to prevent exposure of the maternal immune system to paternal antigens expressed by fetal cells. This clearance of apoptotic cells is crucial to the resolution of local inflammation and thus, vital for the maintenance of pregnancy [15] [16] [17] . Recently, we and others [18 -21] have shown that hCG can promote the innate functions of M, such as releasing oxygen radicals and clearing apoptotic cells. These in vitro studies suggest that hCG can contribute to the maintenance of pregnancy by influencing M function. However, so far, no data are available about the effect of hCG on M function in vivo.
i.p. injection of TG broth has been broadly used to induce acute inflammation in the peritoneal cavity of mice. This inflammatory response shows clearly defined sequential steps of disease development starting with the influx of PMN and monocytes (1-4 h) [21] and followed by a M-dominated infiltrate (40 -72 h) recruitment in the peritoneal cavity. The inflammation is accompanied by increased cytokine levels in the peritoneal fluid [22] [23] [24] [25] . Resident M have been suggested to be the initiators of the PMN recruitment and cytokine production in the peritoneum. Mice with higher numbers of resident M in the peritoneal cavity exhibited an increased and accelerated influx of PMN upon TG administration [26] . In addition, inhibition of the release of chemotactic factor(s) by resident M blocked the migration of PMN into the inflamed peritoneal cavity [27] . Resident M also play a role in the induction of IL-12 and the chemokines CCL3 and CCL5 in TG-induced peritonitis [28] . The above data suggest that in this model, resident M control the acute inflammation by acting as "alarm cells" and triggering several defense mechanisms.
To investigate the hypothesis that hCG reduces inflammation by modifying M function, we used the TG-induced peritonitis model for inflammation. Therefore, we investigated the effect of hCG on cell recruitment and cytokine production in vivo. In these experiments, we observed that hCG pretreatment decreased TNF-␣, IL-6, PTX3, CCL3, and CCL5 levels in TG-induced peritonitis but increased the number of peritoneal cells, especially PMN and monocytes, compared with mice injected with TG only. To study the specific role of M, clodronate liposomes were used to deplete the phagocytic cells from the peritoneal cavity. M phagocytosed the liposomes, resulting in accumulation of clodronate liposomes followed by apoptosis [29, 30] . Our study shows that M are the main responsive cells upon hCG pretreatment. This observation is of importance to understand the harmless sterile inflammatory state of pregnancy, as well as the therapeutic effect of hCG in acute inflammation.
MATERIALS AND METHODS

Mice
Specific pathogen-free C57BL/6 female mice were purchased from Harlan (Horst, The Netherlands). The mice were housed in micro-isolator cages and given mouse chow and water ad libitum in the animal care facility at Erasmus MC (Rotterdam, The Netherlands). Mice were 8 weeks of age when subjected to i.p. injection with TG broth and/or clodronate liposomes. All experiments were performed with the approval of the Erasmus MC Animal Welfare Committee.
TG-induced peritonitis
Mice were injected i.p. with hCG (300 U/20 g body weight, Pregnyl , Organon, Oss, The Netherlands) or PBS in a volume of 200 L. The hCG concentration was optimized from former experiments [9, 10] . One hour later, 1 mL sterile 4% Brewer's TG broth (Sigma-Aldrich, Poole, UK) was injected i.p. per mouse; PBS was used as a control. At different time-points as indicated, the mice were killed, and the peritoneal cavity was flushed with 4 mL cold PBS and 1 mL air to harvest cells. The collected peritoneal cells were counted and prepared for phenotypic analysis by flow cytometry and immunocytochemistry or incubated with Annexin V and PI (Calbiochem, Darmstadt, Germany) for apoptosis detection. The peritoneal fluids were used for cytokine measurement by ELISA. LPS contamination in Pregnyl was excluded by experiments using polymyxin B [18] .
In vivo M depletion by clodronate liposomes
Clodronate-loaded liposomes (dichloromethylene bisphosphonate, a gift from Roche Diagnostics GmbH, Mannheim, Germany) were prepared as described previously [29] . Mice were injected twice i.p. for 2 consecutive days with clodronate liposomes in a volume of 200 L/mouse, containing ϳ2 mg liposome-entrapped clodronate. Consecutive injection was used to obtain a complete depletion of phagocytic cells in the peritoneum. One day after the second liposome application, mice were injected i.p. with hCG (300 U/20 g body weight) or PBS in a volume of 200 L. One hour later, inflammation was induced by TG as described above. Four hours afterward, the mice were killed, and the peritoneal cells were collected and analyzed by flow cytometry. The peritoneal fluids were used for cytokine measurement by ELISA.
PBS was used as a control for clodronate-loaded liposomes, as liposomes without clodronate induced a mild inflammation in vivo and in vitro (data not shown).
Flow cytometry
The peritoneal cells were collected and labeled with the following antibodies: BM8-bio (BMA Biomedicals, Augst, Switzerland), Ly-6C-FITC (ER-MP20, Erasmus MC), and streptavidin-PerCP, CD11b-allophycocyanin, Ly-6G-PE, and IgG control (all from BD PharMingen, Erembodegem-Aalst, Belgium) and analyzed by flow cytometry. In between incubations, cells were washed twice with PBS ϩ 5% BSA (Celliance Corp., Norcross, GA, USA). All incubations were performed at room temperature. The data were analyzed by WinMDI 2.8 software and depicted by mean fluorescence intensity and/or percentage of cells. Determination of different cell types has been described as before [23] .
Apoptotic cells were detected by Annexin V and PI staining (Calbiochem).
ELISA
CCL3 and CCL5 are also known as MIP-1␣ and RANTES, respectively. ELISA kits for the detection of murine TNF-␣, IL-6, and IL-10 (Biosource International, Camarillo, CA, USA) and IL-12p40, CCL3, and CCL5 (R&D Systems, Oxen, UK) were used according to the protocols supplied by the manufacturer. In short, plates were coated with capture antibody overnight. After blocking by PBS-1% BSA for 2 h at room temperature, peritoneal lavage fluid and standards were then added and incubated for 2 h at room temperature. After washing, the biotin-labeled detection antibody was added followed by incubation with streptavidin-HRP for 30 min. Chromogen tetramethylbenzidine was added for 30 min, followed by the addition of the stop solution. In between incubations, the plates were washed with PBS-0.05% Tween. The absorbance was measured at 450 nm or 450 and 650 nm by an ELISA reader.
Murine PTX3 mRNA measurement
Total RNA was extracted from lysed peritoneal-recruited cells. High-quality RNA was extracted using an RNeasy Mini Kit (Qiagen, Hilden, Germany) according to the protocol supplied by the manufacturer. cDNA was synthesized using the Superscript first-strand synthesis system for RT-PCR (Invitrogen, Carlsbad, CA, USA), according to the manufacturer's instructions. Mouse quantitative real-time PCR was performed and analyzed using an ABI 7700 sequence detection system (Applied Biosystems, Foster City, CA, USA) and Taqman probe-based chemistry. Primers for mouse PTX3 (Mm00477267_g1) and the household gene ABL were supplied by Primer Express™ (Applied Biosystems). Each PCR sample was run in duplicate. The mean value of the two reactions was defined as representative of the sample. The resulting PTX3 C T values were expressed relative to an ABL C T . To ease interpretation of results, the following equation: 2 (ABL-PTX3) ϫ 100% was used for the figure. Therefore, an increase is proportional to an increase in expression of the particular target gene.
Immunofluorescence staining
For immunofluorescence staining, cytospin slides were fixed with methanol for 5 s followed by acetone for 15 s at -20°C. Incubation with the first antibody BM8-bio, Ly-6G-PE, or negative control rat-IgG2a (PH2-4a, own laboratory) was performed for 1 h at room temperature, followed by a 30-min incubation with Texas Red-coupled goat anti-rat antibody (Caltag, San Francisco, CA, USA) in the presence of 2% normal mouse serum. For double staining, slides were stained for intracellular IL-6-FITC, TNF-␣-FITC, or negative control rat IgG2a-FITC (all from BD PharMingen). In between the steps, slides were washed with PBS-Tween 20. In the end, the slides were mounted in DAPI-containing Vectashield (Vector Laboratories Inc., Burlingame, CA, USA) and examined using a Zeiss Axioplan 2 imaging fluorescence microscope (Zeiss, Göttingen, Germany).
Statistical analyses
Data are expressed as mean values Ϯ sem in all figures. All statistical analyses were performed using Student's t-test. Among these, an ANOVA test has also been applied (see Fig. 1 ). P values Ͻ0.05 were considered significant. *, P Ͻ 0.05; **, P Ͻ 0.01; ***, P Ͻ 0.001.
RESULTS
hCG pretreatment increases PMN and monocyte recruitment in inflammation
To study the cell recruitment in peritoneal cavity, mice were pretreated with hCG i.p. and 1 h later, i.p.-injected with sterile TG to induce peritonitis. Similar to previous experiments [23] , 4 h after TG injection, we found an increase of total inflammatory cells, mainly consisting of PMN (Ϸ70%) identified as Ly-6G high and monocytes identified as Ly-6G -CD11b high BM8 med . At 72 h, the infiltrate was characterized by decreased numbers of PMN and increased numbers of monocytes and M (60 -80%) identified as Ly-6G med CD11b high BM8 high compared with 4 h after TG injection (Fig. 1A) . In the control group without TG injection, 72 h after hCG treatment, an increased total cell number, mainly consisting of M, was observed (Fig. 1A) . hCG pretreatment followed by TG injection induced increased total cell numbers. This was a result of increased PMN and monocyte recruitment into the peritoneal cavity at 4 h compared with PBS-pretreated mice. At 72 h after TG injection, hCG pretreatment showed no differences on inflammatory cell numbers (Fig. 1A) . Analysis of the percentages of the different cell types showed similar results as the absolute numbers (data not shown). In Figure 1 , an ANOVA test has been applied for statistical analysis. An ANOVA test is an extension of the independent group two-tailed Student's t-test when there are more than two groups. Here, we compared groups without and with TG, TG without and with hCG, and no TG (PBS) with and without hCG.
Analysis of minor inflammatory populations of T and B cells, dendritic cells, and NK cells using CD3, B220, CD11c, and NK1.1 labeling revealed increased numbers of all of these subsets in the peritoneal cavity upon induction of inflammation, but hCG did not influence their influx significantly (data not shown).
hCG pretreatment prevents cell death induced by inflammation
To investigate the mechanism of hCG-induced increased cell recruitment, we studied whether hCG influenced the induction of apoptosis. By staining for Annexin V and PI, early and late apoptotic cells were detected as AnnV ϩ PI -and AnnV ϩ PI ϩ , respectively. Without the induction of inflammation by TG, hCG treatment did not affect the number of apoptotic cells in the peritoneal cavity (Fig. 1B) . Four hours after TG injection, an increased cell death, characterized by early and late apoptotic cells, was observed. hCG pretreatment decreased the percentage of total apoptotic cells from 2.5% to 1.7% comprising reductions in early and late apoptotic cells (Fig. 1B) .
hCG pretreatment decreases IL-6 and TNF-␣ production
TG-induced inflammation is characterized by the increase of several cytokines a.o. IL-6, TNF-␣, and IL-12p40. The level of these cytokines increased in peritoneal lavage fluid at 2 h and 4 h after injection, followed by a decrease toward basal level from 24 h onward (Fig. 2, A-D) . Without inflammation, hCG treatment did not affect the proinflammatory cytokine levels (data not shown). hCG pretreatment of TG-induced inflammation decreased the levels of IL-6 significantly and even more of TNF-␣ at 2 h and 4 h without changing the kinetics (Fig. 2, A  and B) . hCG pretreatment mediated a retained elevation of the IL-10 level at 72 h and did not affect the production of IL-12p40 (Fig. 2 , C and D) compared with PBS pretreatment of TG-induced inflammation. hCG pretreatment did not affect the expression of IL-12p70 and IL-1␤ (data not shown).
hCG pretreatment decreases the production of TNF-␣-inducible factors
As inflammation-related TNF-␣ production was affected most strongly by hCG pretreatment, we evaluated the biological significance of this finding. TNF-␣-inducible factors, such as PTX3, CCL3, CCL5, and MIF, which are closely involved in the inflammatory response, were studied in detail.
PTX3 is a TNF-␣-inducible factor that is quickly produced upon triggering of inflammation. TG application resulted in increased PTX3 mRNA expression by recruited cells at 2 h and 4 h (Fig. 3A) . Without the induction of inflammation by TG, hCG treatment did not affect the PTX3 level compared with untreated mice. hCG pretreatment of TG-induced inflam-mation decreased the PTX3 mRNA expression significantly at 4 h compared with PBS pretreatment (Fig. 3A) .
Similar to the previous findings, hCG pretreatment did not change the minimal presence of CCL3 and CCL5 in the peritoneal lavage fluid compared with PBS-injected mice in the absence of inflammation (Fig. 3, B and C) . Upon TG injection, CCL3 and CCL5 were strongly induced, reaching a maximal level at 4 h followed by a decrease from 4 h onward to reach a basal level at Day 5 and 24 h, respectively (Fig. 3, B and C). hCG pretreatment decreased the production of CCL3 significantly at 4 h and 72 h and decreased the production of CCL5 at 2 h and 4 h without changing the kinetics of CCL3 and CCL5 production (Fig. 3, B and C) . M MIF is also a TNF-␣-inducible gene relevant to the observed, increased cell recruitment. Therefore, MIF was studied in hCG-pretreated mice. At 4 h after hCG pretreatment of TGinduced inflammation, MIF was decreased significantly also (data not shown), in line with the findings mentioned above.
M and PMN produce IL-6 and TNF-␣ upon peritoneal inflammation
To establish which cell type(s) were responsible for the production of IL-6 and TNF-␣ upon TG administration, doublestaining for BM8 ϩ monocytes/M or Ly-6G ϩ PMN in combination with intracellular IL-6 or TNF-␣ was performed on cells recruited to the peritoneal cavity 2 h after TG injection. At this time-point, the majority of the cells in the lavage fluid was Ly-6G
ϩ PMN, and a minority was BM8 ϩ monocytes/M (Fig.  4A) . BM8 ϩ monocytes/M can produce TNF-␣ and IL-6, as all BM8 ϩ cells are positive for TNF-␣ and IL-6 (Fig. 4, B and D) . Here, we compared groups without and with TG, TG without and with hCG, and no TG (PBS) with and without hCG. *, P Ͻ 0.05; **, P Ͻ 0.01; ***, P Ͻ 0.001.
Similar to BM8
ϩ cells, Ly-6G ϩ PMN can also produce TNF-␣ and IL-6 (Fig. 4, C and E) . In contrast, 4 h after TG injection, some TNF-␣ ϩ cells were BM8 ϩ ; no TNF-␣ ϩ Ly-6G ϩ cells were present (data not shown). Most of the IL-6 bright cells were only BM8 ϩ ; some IL-6 low cells were Ly-6G ϩ at 4 h (data not shown). The negative (isotype) control is completely dark (Fig.  4A) . Similar results were obtained in hCG-pretreated mice after the induction of peritoneal inflammation.
Resident M contribute significantly to the observed decrease of inflammation after hCG pretreatment
Considering the role of resident M in the initiation of inflammation (upon TG injection), we depleted resident M by clodronate liposomes to investigate whether the modulating effect of hCG pretreatment in TG-induced peritonitis was mediated by resident M.
Clodronate liposome treatment quantitatively depleted resident M, defined as SSC med-high BM8 high Ly-6C med CD11b high cells (Fig. 5A) . Conversely, PMN are BM8 med Ly-6G high . Four hours after TG injection into clodronate liposomes-treated animals, we observed the full depletion of resident M, and the appearance of SSC med BM8 med Ly-6C high CD11b high cells, which are considered to be the newly recruited monocytes/M (Fig.  5A) . After M depletion, hCG pretreatment did not result in an increase of M numbers in the peritoneal cavity (Fig. 5B) .
Upon TG injection, hCG pretreatment increased the PMN number as depicted in Figures 1A and 5B. Without hCG treatment, M depletion resulted in decreased PMN recruitment after TG injection, in line with a role for resident M in the PMN recruitment. When resident M were depleted, hCG pretreatment did not increase PMN recruitment in the peritoneal cavity of TG-injected mice. Instead, a significant decrease in PMN number was observed compared with nondepleted hCGtreated mice, suggestive of a role of resident M in the hCGinduced, increased PMN influx. When the data were expressed as percentage of cells instead of absolute numbers, the result was similar (Fig. 5B) .
To investigate the contribution of resident M to the observed hCG-mediated decrease in inflammatory cytokine production in TG-injected mice, peritoneal lavage fluid was collected 2 days after depletion of the resident M and 4 h after induction of inflammation. Independent of hCG stimulation, this M depletion resulted in a lower IL-6 level, demonstrating that resident M contribute significantly to the IL-6 production in inflammation (Fig. 5C ). When resident M were depleted, hCG pretreatment did not decrease the IL-6 production further in TG-induced inflammation, suggestive of a contribution of resident M to the decrease of the IL-6 level by hCG pretreatment (Fig. 5C) .
Upon TG injection, hCG pretreatment not only decreased the IL-6 level but also the TNF-␣ level (Figs. 2B and 5C ). However, M depletion did not affect the TNF-␣ level in TG-induced inflammation, suggesting that cells other than the resident M were the main TNF-␣ producers (Fig. 5C) . hCG pretreatment in combination with depletion of resident M did not cause a decrease of the TNF-␣ production compared with hCG pretreatment without depletion, strongly suggesting a role for resident M in mediating hCG-induced suppression of TNF-␣ production by other cell types (Fig. 5C) . 
DISCUSSION
Our earlier in vitro experiments have shown that hCG influences M directly [18] . In particular, their innate immune effector functions, such as radical production and phagocytosis of apoptotic cells, are increased by hCG. Pregnancy has been proposed to be a state of controlled inflammation [2] . We hypothesized that hCG could play an important role in the control of inflammation via modifying M function, and therefore, we studied the effect of hCG cytokine production and cell recruitment in TG-induced peritonitis in a murine in vivo model.
In the present study, we showed that hCG pretreatment induced increased cell recruitment, especially of PMN and monocytes, in the peritoneal cavity at 4 h after TG injection. In line with literature data indicating that resident M are important triggers of PMN recruitment [26, 27] , we found that resident M depletion resulted in diminished PMN recruitment into the peritoneal cavity. In addition, hCG pretreatment of resident M-depleted mice did not increase and even decreased PMN numbers upon TG injection, strongly suggesting that the observed, increased PMN influx upon hCG pretreatment is via modulating the resident M function. The increased cell recruitment upon hCG pretreatment in TG-induced peritonitis was partially a result of diminished cell apoptosis. However, the observed decrease in the percentage of apoptotic cells was small compared with the increased cell recruitment upon hCG pretreatment. The possible reason for this is that the apoptosis measurement is at a single time-point, and the cell recruitment is the accumulated effect until the moment of sampling. The decreased apoptosis we observed is in line with the former findings on hCG and apoptosis, as hCG has been found to induce VEGF production, and the combination of hCG and VEGF protected cells from apoptosis [31, 32] . Changes in cell adhesion may also contribute to the observed, increased cell influx upon hCG pretreatment. We found that hCG increased the adhesive properties of human monocytes in vitro (data not shown). These data suggest that in addition to the decreased apoptosis, other mechanisms may contribute to the observed accumulation of cells in the peritoneal cavity upon hCG pretreatment. It remains to be established why hCG induces an influx of PMN and monocytes when their proinflammatory functions are blocked afterward in acute inflammation. This feature to reduce further damage from infection while preventing a massive cell death can be beneficial to pregnancy.
Earlier, we and others [9 -11] showed that hCG inhibits SIRS, autoimmune type I diabetes development, and Sjogren's syndrome-like exocrinopathy in mice. The present study sheds some light on the factors and cell types affected by hCG. Upon TG injection, hCG pretreatment resulted in decreased levels of TNF-␣, IL-6, MIF, CCL3, and CCL5 at 4 h and an increased IL-10 level at 72 h compared with control, TG-injected mice. TNF-␣, IL-6, MIF, CCL3, and CCL5 are proinflammatory factors that increase significantly upon the induction of inflammation and can amplify inflammatory responses leading to immunopathology, whereas IL-10 is generally believed to be an anti-inflammatory cytokine. Furthermore, CCL3 and CCL5 mainly attract mononuclear phagocytes, including monocytes and M [33] . The observed decrease in CCL3 and CCL5, as well as CCL2 (MCP-1; data not shown) upon hCG pretreat- ment, excludes the possibility that these chemokines account for the increased numbers of PMN and monocytes in the peritoneal cavity after hCG pretreatment. Thus, our data support a beneficial role for hCG in reducing inflammation in TG-induced peritonitis in mice by influencing cytokine and chemokine expression. The increased cell number in the peritoneal cavity is partially a result of prolonged cell survival rather than increased cellular influx. However, it should be noticed that we studied a selection of the chemokines considered relevant. Whether the same mechanism also plays a role in the inhibition of SIRS and diabetes development in mice remains to be established.
PTX3 is a recently defined acute-phase protein that is produced quickly in inflammatory conditions such as endotoxic shock and infection. Furthermore, its expression level correlates with the severity of such conditions [34] . High levels of PTX3 are observed in serum from pregnant females [35] , in line with the hypothesis that pregnancy is a controlled inflammatory condition. These increased PTX3 levels are suggestive of induction by factors elevated in pregnancy. Interestingly, after hCG pretreatment of TG-induced peritonitis, we found a decreased PTX3 mRNA expression in the cells recruited to the peritoneal cavity. This emphasizes that hCG can influence the inflammation, but this does not explain the increased PTX3 levels in pregnancy. The decreased PTX3 expression after hCG pretreatment may be explained by the decreased TNF-␣ level, as PTX3 was first described as a TNF-stimulated gene (TSG-14) [36] . Interestingly, CCL3, CCL5, and MIF are also TNF-␣-inducible genes [37] [38] [39] . Therefore, the decreased production of these TNF-␣-inducible factors points toward a dominant role of a hCG-induced decrease of TNF-␣ production in the control of inflammation. The kinetic data are indicative of such a mechanism, as hCG pretreatment decreased the TNF-␣ level in TG-induced peritonitis, followed by a decrease in PTX3, CCL3, CCL5, and MIF expression.
Furthermore, it has been shown that hCG inhibits NF-B and AP-1 activation in cancer cells and ovarian cells [40, 41] . The inhibitory effect of hCG on NF-B was also observed in human Jurkat T cells (unpublished data). Once activated, NF-B regulates the expression of almost 400 different genes, including cytokines such as TNF-␣, IL-6, and several chemokines. Further studies are needed to elucidate the role of NF-B in the immunomodulatory effect of hCG.
Shortly after inflammation induction, IL-6 can be produced by Ly-6G ϩ PMN and BM8 ϩ monocytes/M. However, peritoneal mesothelial cells can also secrete IL-6 after inflammatory signals such as IL-1␤ and TNF-␣ [42, 43] . Mesothelial cells are potential producers of TNF-␣ in peritonitis too [44, 45] . Resident M depletion and hCG pretreatment resulted in similar decreased levels of IL-6 compared with control, TG-injected mice, suggesting a contribution of recruited M to the hCG effect on IL-6 production. Similar to a former study describing that PMN can produce TNF-␣ upon inflammation [46] , we found that TNF-␣ is detectable in Ly-6G ϩ PMN as well as in BM8 ϩ monocytes/M shortly after induction of inflammation. Upon resident M depletion, the level of TNF-␣ remained unchanged, suggesting that these cells are not the main producers of TNF-␣ in our TG model, although immunochemistry showed that 2 h after TG injection, most of BM8 ϩ cells are TNF-␣ ϩ . By FACS analysis, we observed two subpopulations of BM8 ϩ cells: BM8 high resident M, which are depleted by clodronate liposome application, and BM8 med myelomonocytic cells, including newly recruited inflammatory M, which are unaffected by the prior clodronate liposome-mediated depletion. It has been described that TG-elicited peritoneal M are more proliferative compared with resident M [47, 48] and produce ϳ10 times more TNF-␣ [49] . Therefore, we suggest that the TNF-␣ ϩ BM8 ϩ cells are newly recruited M. Upon resident M depletion, hCG pretreatment did not decrease TNF-␣ production, suggesting that resident M are prime responders to hCG. Therefore, these M likely mediate the suppression of TNF-␣ production by other cells such as PMN and resident/ recruited M.
It should be noted that liposomal clodronate administration could result in a systemic alteration of mononuclear phagocytic cells, including spleen, liver, pancreas, blood, and bone marrow. Although there is a systemic change, the inflammatory responses to TG injection in the peritoneum are still present without clodronate liposome treatment, only the resident M are present or absent. Therefore, we expect huge changes in cytokine levels between sera collected from clodronate liposome groups and nonclodronate liposome groups, but this information is less relevant for the observed local effect of hCG. Moreover, TG-induced local inflammation at the 4-h point is dominated by the influx of PMNs, which themselves are not influenced by clodronate treatment; thus, the effect of the clodronate on the local inflammatory response is likely to be a result of the depletion of resident M. In our opinion, the systemic change did not influence the local effect of hCG in alleviating local acute inflammation. Moreover, depletion itself also induces a local inflammatory process, resulting in increased inflammatory cytokine and chemokine production to recruit M.
On the other hand, by its inhibition of TNF-␣ and IL-6 and the induction of IL-10, hCG seems to alternatively activate M. It has been shown that Th2-type cytokines such as IL-4, 1L-13, IL-10, or TGF-␤ induce M with immunosuppressive activities [50] , and hCG appears to act in a similar manner. This poten- tial of hCG is beneficial for pregnancy, contributing to the reduction of maternal rejection toward the fetus. There seem to be contradictions between our previous in vitro data about enhanced M function by hCG [18] and the present in vivo results about hCG alleviating inflammation by dampening M function. However, several points need to be highlighted in this regard: The sources of M differed, as in our previous study, we used M-CSF-stimulated bone marrowderived M cultured in vitro, and here, we found the suppressive effect to be related to resident peritoneal M, which have a distinct derivation, phenotype, and responsiveness; and the triggers are different, as formerly, we used IFN-␥ to stimulate M, and in this study, TG (chemical) was applied to create a sterile inflammatory condition, targeting not only M but many more cell types present in the peritoneal cavity. Despite these disparities, hCG seems to have beneficial, immunological effects in pregnancy, as on one hand, it enhances innate immunity by increasing the cellular function of M, such as killing bacteria through release of NO and reactive oxygen species, and on the other hand, hCG down-regulates systemic proinflammatory factor production and thus, contributes to the control of the inflammatory condition during pregnancy.
Taken together, in this study, we observed that hCG contributes to the modulation of TG-induced peritoneal inflammation by affecting resident M function, which results in decreased production of proinflammatory factors such as IL-6, TNF-␣, PTX3, CCL3, and CCL5. This may explain why hCG can resolve inflammatory conditions such as SIRS and may contribute to the control of the sterile inflammatory condition during pregnancy.
